RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Robert R. Alfano to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Robert R. Alfano has written about Drug Administration Schedule.
Robert R. Alfano
Connection Strength
0.049
Drug Administration Schedule
  1. Gambardella A, Licata G, Calabrese G, De Rosa A, Alfano R, Argenziano G. Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata. Dermatitis. 2021 Oct 01; 32(1S):e85-e86.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support